Cost-effectiveness of low-dose rivaroxaban and aspirin versus aspirin alone in people with peripheral or carotid artery disease: An Australian healthcare perspective

Ella Zomer, Si Si, Thomas R Hird, Danny Liew, Alice J Owen, Andrew Tonkin, Christopher M Reid, Zanfina Ademi

Research output: Contribution to journal › Article › peer-review

18 Citations (SciVal)

Fingerprint

Dive into the research topics of 'Cost-effectiveness of low-dose rivaroxaban and aspirin versus aspirin alone in people with peripheral or carotid artery disease: An Australian healthcare perspective'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science